Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

The development of biomarkers for autoimmune diseases has been hampered by a lack of understanding of disease etiopathogenesis and of the mechanisms underlying the induction and maintenance of inflammation, which involves complex activation dynamics of diverse cell types. The heterogeneous nature an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Nitya, Mei, Henrik E, Chen, Shih-Yu, Hale, Matthew, Nolan, Garry P, Maecker, Holden T, Genovese, Mark, Fathman, C Garrison, Whiting, Chan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436107/
https://www.ncbi.nlm.nih.gov/pubmed/25981462
http://dx.doi.org/10.1186/s13075-015-0644-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436107/
https://www.ncbi.nlm.nih.gov/pubmed/25981462
http://dx.doi.org/10.1186/s13075-015-0644-z

Ejemplares similares